A new study shows the first drop in obesity in over a decade, driven by weight loss medications like semaglutide.

As the use of adolescent use of GLP-1 medications surges, research looks into their safety and natural alternatives.

A recent study found that moderate drinkers who use weight-loss drugs like Mounjaro tend to drink less alcohol.

How is withdrawing from a research study regulated, what are the rules, and what rights do the human participants have in those case?

A new tailored approach to using GLP-1 receptor agonists for obesity management achieves nearly twice the weight loss.

No one wants to see minors sticking hypodermic needles into themselves. Some new devices being researched won’t require injections.

We continue discussing the alternatives to GLP-1 medications, including natural herbs and supplements. But those come with their own sets of side effects.

How often do doctors prescribe new weight loss drugs to kids? And what reservations and considerations drive their decisions?

One recent study found that gene therapy converts Omega-6 to Omega-3 fatty acids in the body, in other words, turning “harmful fats” into “helpful fats.”

Two recent studies found that adding a digital component to health behavior counseling can reduce childhood obesity risk.

Let’s take a look at how the thinking on obesity has shifted over time and what this means for public health and healthcare.

Utilizing social media, women have taken it upon themselves to communicate with each other, sharing good news and bad news.

Some studies indicate that GLP-1 drugs in conjunction with pregnancy do pose a risk, but the FDA still warns women not to take them during pregnancy.

Obesity treatment has shifted away from advice about diet and exercise to a more scientific understanding of the disease.

What is going on with the relationship between the GLP-1 genre of weight-loss medications and the creation of new humans?

September is the National Childhood Obesity News. To honor it, let’s look at some recent studies in various areas, from dengue fever to baby food nutrition.

One way or another, childhood obesity ends up being everybody’s problem. Agreement is universal on the importance of starting to fight it early.

A new study published in the New England Journal of Medicine sheds light on how GLP-1 drugs could play a critical role in treating obesity in younger children.

Research shows that weight loss drugs, despite their similar mechanisms, can vary in effectiveness.

Is lack of elf-control to blame as one of the causes of childhood obesity. It’s a double-edged sword. Let’s take a look.

In two recent studies, Yale researchers try to identify ways to increase access to effective pediatric obesity treatments.

A child’s early experiences alter gene expression and affect long-term development whether we like it or not, and whether or not we believe it.

Can berberine, a compound derived from plants, offer a safe alternative to widely-used weight loss medications?

There are a few new obesity treatments being actively researched and developed. Let’s take a look.

Digital tools like Telemedicine and mHealth can be valuable for treating and preventing childhood obesity.

Will oral GLP-1s change the game and appeal to those turned off by injectables? According to experts, it depends.

About the GLP-1 drugs, there are currently more questions than answers, and one of them is, are the most important questions even being asked?

Pet cats could serve as valuable animal models for studying the origins and treatments of obesity in humans, according to a new study on feline gut microbes.

As weight-loss aids, GLP-1 drugs are relatively new and untried. When any discovery comes along, questions arise.

The loss of muscle mass that inevitably accompanies fat loss is a hazard to teens who are prescribed a GLP-1 drug. Not surprisingly, seniors are also at risk.